nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—breast cancer	0.292	1	CbGaD
Carbimazole—CYP19A1—Exemestane—breast cancer	0.146	0.291	CbGbCtD
Carbimazole—CYP19A1—Letrozole—breast cancer	0.124	0.247	CbGbCtD
Carbimazole—CYP19A1—Anastrozole—breast cancer	0.111	0.22	CbGbCtD
Carbimazole—CYP19A1—Raloxifene—breast cancer	0.0561	0.111	CbGbCtD
Carbimazole—CYP19A1—Tamoxifen—breast cancer	0.037	0.0736	CbGbCtD
Carbimazole—CYP19A1—Paclitaxel—breast cancer	0.0288	0.0573	CbGbCtD
Carbimazole—CYP19A1—corpus luteum—breast cancer	0.0112	0.465	CbGeAlD
Carbimazole—TPO—adipose tissue—breast cancer	0.00274	0.114	CbGeAlD
Carbimazole—TPO—adrenal gland—breast cancer	0.00246	0.102	CbGeAlD
Carbimazole—TPO—endocrine gland—breast cancer	0.00213	0.0885	CbGeAlD
Carbimazole—CYP19A1—endometrium—breast cancer	0.000867	0.036	CbGeAlD
Carbimazole—CYP19A1—uterus—breast cancer	0.000799	0.0332	CbGeAlD
Carbimazole—CYP19A1—adipose tissue—breast cancer	0.000781	0.0324	CbGeAlD
Carbimazole—CYP19A1—female reproductive system—breast cancer	0.000718	0.0298	CbGeAlD
Carbimazole—CYP19A1—adrenal gland—breast cancer	0.000701	0.0291	CbGeAlD
Carbimazole—CYP19A1—female gonad—breast cancer	0.000653	0.0271	CbGeAlD
Carbimazole—CYP19A1—endocrine gland—breast cancer	0.000608	0.0252	CbGeAlD
Carbimazole—CYP19A1—lymph node—breast cancer	0.00042	0.0174	CbGeAlD
Carbimazole—Infection—Mitoxantrone—breast cancer	9.84e-05	0.000845	CcSEcCtD
Carbimazole—Infection—Irinotecan—breast cancer	9.84e-05	0.000845	CcSEcCtD
Carbimazole—Discomfort—Fluorouracil—breast cancer	9.78e-05	0.000839	CcSEcCtD
Carbimazole—Pruritus—Melphalan—breast cancer	9.73e-05	0.000835	CcSEcCtD
Carbimazole—Nervous system disorder—Irinotecan—breast cancer	9.72e-05	0.000834	CcSEcCtD
Carbimazole—Agranulocytosis—Capecitabine—breast cancer	9.7e-05	0.000833	CcSEcCtD
Carbimazole—Thrombocytopenia—Irinotecan—breast cancer	9.7e-05	0.000833	CcSEcCtD
Carbimazole—Thrombocytopenia—Mitoxantrone—breast cancer	9.7e-05	0.000833	CcSEcCtD
Carbimazole—Haemoglobin—Docetaxel—breast cancer	9.69e-05	0.000832	CcSEcCtD
Carbimazole—Haemorrhage—Docetaxel—breast cancer	9.64e-05	0.000827	CcSEcCtD
Carbimazole—Hepatitis—Docetaxel—breast cancer	9.64e-05	0.000827	CcSEcCtD
Carbimazole—Skin disorder—Mitoxantrone—breast cancer	9.62e-05	0.000826	CcSEcCtD
Carbimazole—Infection—Gemcitabine—breast cancer	9.59e-05	0.000823	CcSEcCtD
Carbimazole—Urticaria—Vinorelbine—breast cancer	9.54e-05	0.000819	CcSEcCtD
Carbimazole—Body temperature increased—Vinorelbine—breast cancer	9.5e-05	0.000815	CcSEcCtD
Carbimazole—Pruritus—Goserelin—breast cancer	9.49e-05	0.000814	CcSEcCtD
Carbimazole—Nervous system disorder—Gemcitabine—breast cancer	9.46e-05	0.000812	CcSEcCtD
Carbimazole—Feeling abnormal—Thiotepa—breast cancer	9.45e-05	0.000811	CcSEcCtD
Carbimazole—Thrombocytopenia—Gemcitabine—breast cancer	9.45e-05	0.000811	CcSEcCtD
Carbimazole—Infection—Fluorouracil—breast cancer	9.43e-05	0.000809	CcSEcCtD
Carbimazole—Haemoglobin—Capecitabine—breast cancer	9.38e-05	0.000805	CcSEcCtD
Carbimazole—Skin disorder—Gemcitabine—breast cancer	9.37e-05	0.000805	CcSEcCtD
Carbimazole—Nausea—Chlorambucil—breast cancer	9.37e-05	0.000804	CcSEcCtD
Carbimazole—Haemorrhage—Capecitabine—breast cancer	9.33e-05	0.000801	CcSEcCtD
Carbimazole—Hepatitis—Capecitabine—breast cancer	9.33e-05	0.000801	CcSEcCtD
Carbimazole—Nervous system disorder—Fluorouracil—breast cancer	9.3e-05	0.000799	CcSEcCtD
Carbimazole—Thrombocytopenia—Fluorouracil—breast cancer	9.29e-05	0.000797	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—breast cancer	9.27e-05	0.000796	CcSEcCtD
Carbimazole—Ill-defined disorder—Paclitaxel—breast cancer	9.19e-05	0.000788	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AURKA—breast cancer	9.17e-05	0.00144	CbGpPWpGaD
Carbimazole—Urticaria—Thiotepa—breast cancer	9.11e-05	0.000782	CcSEcCtD
Carbimazole—Body temperature increased—Thiotepa—breast cancer	9.07e-05	0.000778	CcSEcCtD
Carbimazole—Headache—Vinblastine—breast cancer	9.06e-05	0.000777	CcSEcCtD
Carbimazole—Angioedema—Paclitaxel—breast cancer	9.05e-05	0.000776	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mitoxantrone—breast cancer	9.03e-05	0.000775	CcSEcCtD
Carbimazole—Malaise—Paclitaxel—breast cancer	8.93e-05	0.000766	CcSEcCtD
Carbimazole—Leukopenia—Paclitaxel—breast cancer	8.86e-05	0.000761	CcSEcCtD
Carbimazole—Rash—Tamoxifen—breast cancer	8.85e-05	0.00076	CcSEcCtD
Carbimazole—Hypersensitivity—Vinorelbine—breast cancer	8.85e-05	0.00076	CcSEcCtD
Carbimazole—Dermatitis—Tamoxifen—breast cancer	8.85e-05	0.000759	CcSEcCtD
Carbimazole—TPO—Metabolism—ALDH1A1—breast cancer	8.83e-05	0.00139	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALDH7A1—breast cancer	8.83e-05	0.00139	CbGpPWpGaD
Carbimazole—Headache—Tamoxifen—breast cancer	8.8e-05	0.000755	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Gemcitabine—breast cancer	8.79e-05	0.000755	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP17A1—breast cancer	8.75e-05	0.00138	CbGpPWpGaD
Carbimazole—Angiopathy—Docetaxel—breast cancer	8.75e-05	0.000751	CcSEcCtD
Carbimazole—Liver function test abnormal—Epirubicin—breast cancer	8.68e-05	0.000745	CcSEcCtD
Carbimazole—Rash—Melphalan—breast cancer	8.67e-05	0.000744	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—PTGS1—breast cancer	8.66e-05	0.00136	CbGpPWpGaD
Carbimazole—Dermatitis—Melphalan—breast cancer	8.66e-05	0.000743	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Fluorouracil—breast cancer	8.64e-05	0.000742	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP17A1—breast cancer	8.63e-05	0.00136	CbGpPWpGaD
Carbimazole—Eosinophilia—Methotrexate—breast cancer	8.59e-05	0.000738	CcSEcCtD
Carbimazole—Nausea—Vinblastine—breast cancer	8.59e-05	0.000737	CcSEcCtD
Carbimazole—Alopecia—Docetaxel—breast cancer	8.52e-05	0.000731	CcSEcCtD
Carbimazole—Pruritus—Vinorelbine—breast cancer	8.5e-05	0.000729	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2D6—breast cancer	8.49e-05	0.00134	CbGpPWpGaD
Carbimazole—Angiopathy—Capecitabine—breast cancer	8.47e-05	0.000727	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PAK1—breast cancer	8.46e-05	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADSL—breast cancer	8.46e-05	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FHL2—breast cancer	8.46e-05	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UMPS—breast cancer	8.46e-05	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PHGDH—breast cancer	8.46e-05	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NME1—breast cancer	8.46e-05	0.00133	CbGpPWpGaD
Carbimazole—Rash—Goserelin—breast cancer	8.46e-05	0.000726	CcSEcCtD
Carbimazole—Hypersensitivity—Thiotepa—breast cancer	8.45e-05	0.000725	CcSEcCtD
Carbimazole—Dermatitis—Goserelin—breast cancer	8.45e-05	0.000725	CcSEcCtD
Carbimazole—Arthralgia—Paclitaxel—breast cancer	8.43e-05	0.000723	CcSEcCtD
Carbimazole—Myalgia—Paclitaxel—breast cancer	8.43e-05	0.000723	CcSEcCtD
Carbimazole—Headache—Goserelin—breast cancer	8.4e-05	0.000721	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2D6—breast cancer	8.38e-05	0.00132	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	8.37e-05	0.000718	CcSEcCtD
Carbimazole—Nausea—Tamoxifen—breast cancer	8.34e-05	0.000716	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—NCOA2—breast cancer	8.34e-05	0.00131	CbGpPWpGaD
Carbimazole—Discomfort—Paclitaxel—breast cancer	8.33e-05	0.000715	CcSEcCtD
Carbimazole—TPO—Metabolism—BRIP1—breast cancer	8.3e-05	0.00131	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LDHB—breast cancer	8.3e-05	0.00131	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HPSE—breast cancer	8.3e-05	0.00131	CbGpPWpGaD
Carbimazole—Alopecia—Capecitabine—breast cancer	8.25e-05	0.000708	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—breast cancer	8.24e-05	0.000707	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—breast cancer	8.2e-05	0.00129	CbGpPWpGaD
Carbimazole—Nausea—Melphalan—breast cancer	8.17e-05	0.000701	CcSEcCtD
Carbimazole—Feeling abnormal—Mitoxantrone—breast cancer	8.16e-05	0.000701	CcSEcCtD
Carbimazole—Feeling abnormal—Irinotecan—breast cancer	8.16e-05	0.000701	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—breast cancer	8.12e-05	0.000697	CcSEcCtD
Carbimazole—Pruritus—Thiotepa—breast cancer	8.12e-05	0.000697	CcSEcCtD
Carbimazole—Eosinophilia—Epirubicin—breast cancer	8.04e-05	0.00069	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—breast cancer	8.03e-05	0.000689	CcSEcCtD
Carbimazole—Infection—Paclitaxel—breast cancer	8.03e-05	0.000689	CcSEcCtD
Carbimazole—Nausea—Goserelin—breast cancer	7.97e-05	0.000684	CcSEcCtD
Carbimazole—Feeling abnormal—Gemcitabine—breast cancer	7.95e-05	0.000683	CcSEcCtD
Carbimazole—Nervous system disorder—Paclitaxel—breast cancer	7.92e-05	0.00068	CcSEcCtD
Carbimazole—Thrombocytopenia—Paclitaxel—breast cancer	7.91e-05	0.000679	CcSEcCtD
Carbimazole—Urticaria—Mitoxantrone—breast cancer	7.87e-05	0.000675	CcSEcCtD
Carbimazole—TPO—Metabolism—ABCC1—breast cancer	7.87e-05	0.00124	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA3—breast cancer	7.87e-05	0.00124	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMMR—breast cancer	7.87e-05	0.00124	CbGpPWpGaD
Carbimazole—Skin disorder—Paclitaxel—breast cancer	7.85e-05	0.000674	CcSEcCtD
Carbimazole—Body temperature increased—Irinotecan—breast cancer	7.83e-05	0.000672	CcSEcCtD
Carbimazole—Body temperature increased—Mitoxantrone—breast cancer	7.83e-05	0.000672	CcSEcCtD
Carbimazole—Feeling abnormal—Fluorouracil—breast cancer	7.82e-05	0.000671	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—breast cancer	7.71e-05	0.000662	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—STK11—breast cancer	7.68e-05	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—breast cancer	7.68e-05	0.00121	CbGpPWpGaD
Carbimazole—Body temperature increased—Gemcitabine—breast cancer	7.63e-05	0.000655	CcSEcCtD
Carbimazole—TPO—Metabolism—PPARGC1B—breast cancer	7.62e-05	0.0012	CbGpPWpGaD
Carbimazole—Neutropenia—Epirubicin—breast cancer	7.6e-05	0.000652	CcSEcCtD
Carbimazole—Rash—Vinorelbine—breast cancer	7.57e-05	0.00065	CcSEcCtD
Carbimazole—Dermatitis—Vinorelbine—breast cancer	7.57e-05	0.000649	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—breast cancer	7.54e-05	0.000647	CcSEcCtD
Carbimazole—Ill-defined disorder—Capecitabine—breast cancer	7.54e-05	0.000647	CcSEcCtD
Carbimazole—Urticaria—Fluorouracil—breast cancer	7.54e-05	0.000647	CcSEcCtD
Carbimazole—Headache—Vinorelbine—breast cancer	7.53e-05	0.000646	CcSEcCtD
Carbimazole—Leukopenia—Docetaxel—breast cancer	7.51e-05	0.000645	CcSEcCtD
Carbimazole—Body temperature increased—Fluorouracil—breast cancer	7.5e-05	0.000644	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP3A4—breast cancer	7.49e-05	0.00118	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AR—breast cancer	7.48e-05	0.00118	CbGpPWpGaD
Carbimazole—Eosinophilia—Doxorubicin—breast cancer	7.44e-05	0.000639	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP3A4—breast cancer	7.39e-05	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1B1—breast cancer	7.36e-05	0.00116	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.36e-05	0.000632	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	7.36e-05	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—breast cancer	7.34e-05	0.00116	CbGpPWpGaD
Carbimazole—Malaise—Capecitabine—breast cancer	7.33e-05	0.000629	CcSEcCtD
Carbimazole—Hypersensitivity—Mitoxantrone—breast cancer	7.3e-05	0.000626	CcSEcCtD
Carbimazole—Hypersensitivity—Irinotecan—breast cancer	7.3e-05	0.000626	CcSEcCtD
Carbimazole—Leukopenia—Capecitabine—breast cancer	7.27e-05	0.000624	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1B1—breast cancer	7.26e-05	0.00114	CbGpPWpGaD
Carbimazole—Rash—Thiotepa—breast cancer	7.23e-05	0.000621	CcSEcCtD
Carbimazole—Dermatitis—Thiotepa—breast cancer	7.23e-05	0.00062	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—breast cancer	7.22e-05	0.00062	CcSEcCtD
Carbimazole—TPO—Metabolism—CA9—breast cancer	7.2e-05	0.00113	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA4—breast cancer	7.2e-05	0.00113	CbGpPWpGaD
Carbimazole—Headache—Thiotepa—breast cancer	7.19e-05	0.000617	CcSEcCtD
Carbimazole—Arthralgia—Docetaxel—breast cancer	7.14e-05	0.000613	CcSEcCtD
Carbimazole—Myalgia—Docetaxel—breast cancer	7.14e-05	0.000613	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—breast cancer	7.14e-05	0.000613	CcSEcCtD
Carbimazole—Nausea—Vinorelbine—breast cancer	7.13e-05	0.000612	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—breast cancer	7.11e-05	0.00112	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.09e-05	0.000609	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—breast cancer	7.06e-05	0.000606	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—breast cancer	7.06e-05	0.000606	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—breast cancer	7.03e-05	0.000603	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—NCOA1—breast cancer	7.03e-05	0.00111	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA2—breast cancer	7.01e-05	0.0011	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX2—breast cancer	7.01e-05	0.0011	CbGpPWpGaD
Carbimazole—Hypersensitivity—Fluorouracil—breast cancer	6.99e-05	0.0006	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—breast cancer	6.98e-05	0.000599	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ABL1—breast cancer	6.95e-05	0.00109	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—breast cancer	6.95e-05	0.00109	CbGpPWpGaD
Carbimazole—Haemorrhage—Methotrexate—breast cancer	6.95e-05	0.000596	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—breast cancer	6.95e-05	0.000596	CcSEcCtD
Carbimazole—TPO—Metabolism—GPX4—breast cancer	6.93e-05	0.00109	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SULT1A1—breast cancer	6.93e-05	0.00109	CbGpPWpGaD
Carbimazole—Arthralgia—Capecitabine—breast cancer	6.92e-05	0.000594	CcSEcCtD
Carbimazole—Myalgia—Capecitabine—breast cancer	6.92e-05	0.000594	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.87e-05	0.00059	CcSEcCtD
Carbimazole—Discomfort—Capecitabine—breast cancer	6.83e-05	0.000587	CcSEcCtD
Carbimazole—Pruritus—Gemcitabine—breast cancer	6.83e-05	0.000586	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—breast cancer	6.82e-05	0.00107	CbGpPWpGaD
Carbimazole—Nausea—Thiotepa—breast cancer	6.81e-05	0.000585	CcSEcCtD
Carbimazole—Infection—Docetaxel—breast cancer	6.8e-05	0.000584	CcSEcCtD
Carbimazole—TPO—Metabolism—IDH1—breast cancer	6.76e-05	0.00107	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA1—breast cancer	6.76e-05	0.00107	CbGpPWpGaD
Carbimazole—Agranulocytosis—Epirubicin—breast cancer	6.76e-05	0.00058	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—breast cancer	6.73e-05	0.00106	CbGpPWpGaD
Carbimazole—Nervous system disorder—Docetaxel—breast cancer	6.72e-05	0.000576	CcSEcCtD
Carbimazole—Pruritus—Fluorouracil—breast cancer	6.71e-05	0.000576	CcSEcCtD
Carbimazole—Thrombocytopenia—Docetaxel—breast cancer	6.71e-05	0.000576	CcSEcCtD
Carbimazole—TPO—Metabolism—NAT2—breast cancer	6.69e-05	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	6.68e-05	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	6.68e-05	0.00105	CbGpPWpGaD
Carbimazole—Feeling abnormal—Paclitaxel—breast cancer	6.66e-05	0.000571	CcSEcCtD
Carbimazole—Skin disorder—Docetaxel—breast cancer	6.65e-05	0.000571	CcSEcCtD
Carbimazole—Infection—Capecitabine—breast cancer	6.59e-05	0.000565	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—breast cancer	6.53e-05	0.000561	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—breast cancer	6.53e-05	0.000561	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—breast cancer	6.53e-05	0.000561	CcSEcCtD
Carbimazole—Nervous system disorder—Capecitabine—breast cancer	6.5e-05	0.000558	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—breast cancer	6.5e-05	0.000558	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—breast cancer	6.5e-05	0.000558	CcSEcCtD
Carbimazole—Thrombocytopenia—Capecitabine—breast cancer	6.49e-05	0.000557	CcSEcCtD
Carbimazole—Skin disorder—Capecitabine—breast cancer	6.44e-05	0.000553	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—COMT—breast cancer	6.44e-05	0.00101	CbGpPWpGaD
Carbimazole—Urticaria—Paclitaxel—breast cancer	6.42e-05	0.000551	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—breast cancer	6.41e-05	0.00101	CbGpPWpGaD
Carbimazole—Body temperature increased—Paclitaxel—breast cancer	6.39e-05	0.000548	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAX—breast cancer	6.37e-05	0.001	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—COMT—breast cancer	6.35e-05	0.001	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HADHB—breast cancer	6.33e-05	0.000997	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—E2F1—breast cancer	6.32e-05	0.000996	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—breast cancer	6.32e-05	0.000995	CbGpPWpGaD
Carbimazole—Angiopathy—Methotrexate—breast cancer	6.3e-05	0.000541	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—breast cancer	6.25e-05	0.000537	CcSEcCtD
Carbimazole—Rash—Irinotecan—breast cancer	6.25e-05	0.000536	CcSEcCtD
Carbimazole—Rash—Mitoxantrone—breast cancer	6.25e-05	0.000536	CcSEcCtD
Carbimazole—Dermatitis—Irinotecan—breast cancer	6.24e-05	0.000536	CcSEcCtD
Carbimazole—Dermatitis—Mitoxantrone—breast cancer	6.24e-05	0.000536	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Docetaxel—breast cancer	6.24e-05	0.000536	CcSEcCtD
Carbimazole—Headache—Mitoxantrone—breast cancer	6.21e-05	0.000533	CcSEcCtD
Carbimazole—Headache—Irinotecan—breast cancer	6.21e-05	0.000533	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—breast cancer	6.14e-05	0.000527	CcSEcCtD
Carbimazole—Rash—Gemcitabine—breast cancer	6.08e-05	0.000522	CcSEcCtD
Carbimazole—Dermatitis—Gemcitabine—breast cancer	6.08e-05	0.000522	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—breast cancer	6.05e-05	0.000519	CcSEcCtD
Carbimazole—Headache—Gemcitabine—breast cancer	6.05e-05	0.000519	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Capecitabine—breast cancer	6.04e-05	0.000518	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—breast cancer	6.02e-05	0.000516	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—breast cancer	6.02e-05	0.000516	CcSEcCtD
Carbimazole—Rash—Fluorouracil—breast cancer	5.98e-05	0.000513	CcSEcCtD
Carbimazole—Dermatitis—Fluorouracil—breast cancer	5.98e-05	0.000513	CcSEcCtD
Carbimazole—Hypersensitivity—Paclitaxel—breast cancer	5.95e-05	0.000511	CcSEcCtD
Carbimazole—Headache—Fluorouracil—breast cancer	5.94e-05	0.00051	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—breast cancer	5.9e-05	0.000506	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—breast cancer	5.89e-05	0.000927	CbGpPWpGaD
Carbimazole—Nausea—Irinotecan—breast cancer	5.88e-05	0.000505	CcSEcCtD
Carbimazole—Nausea—Mitoxantrone—breast cancer	5.88e-05	0.000505	CcSEcCtD
Carbimazole—TPO—Metabolism—MED12—breast cancer	5.87e-05	0.000924	CbGpPWpGaD
Carbimazole—TPO—Metabolism—DPYD—breast cancer	5.87e-05	0.000924	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—breast cancer	5.81e-05	0.000914	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FHL2—breast cancer	5.79e-05	0.000912	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALDOA—breast cancer	5.77e-05	0.000909	CbGpPWpGaD
Carbimazole—Alopecia—Epirubicin—breast cancer	5.75e-05	0.000493	CcSEcCtD
Carbimazole—Nausea—Gemcitabine—breast cancer	5.73e-05	0.000492	CcSEcCtD
Carbimazole—Pruritus—Paclitaxel—breast cancer	5.72e-05	0.000491	CcSEcCtD
Carbimazole—Feeling abnormal—Docetaxel—breast cancer	5.64e-05	0.000484	CcSEcCtD
Carbimazole—Nausea—Fluorouracil—breast cancer	5.64e-05	0.000484	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—breast cancer	5.61e-05	0.000482	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA3—breast cancer	5.61e-05	0.000883	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—breast cancer	5.58e-05	0.000879	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC2A2—breast cancer	5.57e-05	0.000876	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—breast cancer	5.56e-05	0.000875	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—breast cancer	5.5e-05	0.000867	CbGpPWpGaD
Carbimazole—Feeling abnormal—Capecitabine—breast cancer	5.46e-05	0.000469	CcSEcCtD
Carbimazole—Angiopathy—Doxorubicin—breast cancer	5.46e-05	0.000468	CcSEcCtD
Carbimazole—Malaise—Methotrexate—breast cancer	5.45e-05	0.000468	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDK2—breast cancer	5.45e-05	0.000859	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CPT1A—breast cancer	5.45e-05	0.000859	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTR—breast cancer	5.45e-05	0.000859	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG2—breast cancer	5.45e-05	0.000859	CbGpPWpGaD
Carbimazole—Body temperature increased—Docetaxel—breast cancer	5.41e-05	0.000465	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—breast cancer	5.41e-05	0.000465	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	5.38e-05	0.000848	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HPGDS—breast cancer	5.35e-05	0.000842	CbGpPWpGaD
Carbimazole—Alopecia—Doxorubicin—breast cancer	5.32e-05	0.000456	CcSEcCtD
Carbimazole—TPO—Metabolism—HBA1—breast cancer	5.31e-05	0.000837	CbGpPWpGaD
Carbimazole—Urticaria—Capecitabine—breast cancer	5.27e-05	0.000452	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—breast cancer	5.25e-05	0.000451	CcSEcCtD
Carbimazole—Body temperature increased—Capecitabine—breast cancer	5.24e-05	0.00045	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.21e-05	0.000821	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ACHE—breast cancer	5.19e-05	0.000817	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTT1—breast cancer	5.19e-05	0.000817	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATM—breast cancer	5.18e-05	0.000815	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—breast cancer	5.15e-05	0.000812	CbGpPWpGaD
Carbimazole—Arthralgia—Methotrexate—breast cancer	5.15e-05	0.000442	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—breast cancer	5.15e-05	0.000442	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—breast cancer	5.13e-05	0.000808	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.11e-05	0.000439	CcSEcCtD
Carbimazole—Malaise—Epirubicin—breast cancer	5.1e-05	0.000438	CcSEcCtD
Carbimazole—Rash—Paclitaxel—breast cancer	5.09e-05	0.000437	CcSEcCtD
Carbimazole—Dermatitis—Paclitaxel—breast cancer	5.09e-05	0.000437	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—breast cancer	5.09e-05	0.000437	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—breast cancer	5.07e-05	0.000435	CcSEcCtD
Carbimazole—Headache—Paclitaxel—breast cancer	5.06e-05	0.000434	CcSEcCtD
Carbimazole—Hypersensitivity—Docetaxel—breast cancer	5.05e-05	0.000433	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP17A1—breast cancer	4.91e-05	0.000773	CbGpPWpGaD
Carbimazole—Infection—Methotrexate—breast cancer	4.9e-05	0.000421	CcSEcCtD
Carbimazole—Hypersensitivity—Capecitabine—breast cancer	4.88e-05	0.000419	CcSEcCtD
Carbimazole—TPO—Metabolism—ENO1—breast cancer	4.86e-05	0.000765	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS1—breast cancer	4.86e-05	0.000765	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Doxorubicin—breast cancer	4.86e-05	0.000417	CcSEcCtD
Carbimazole—Pruritus—Docetaxel—breast cancer	4.85e-05	0.000416	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—breast cancer	4.84e-05	0.000415	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—breast cancer	4.83e-05	0.000415	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—breast cancer	4.82e-05	0.000414	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—breast cancer	4.82e-05	0.000414	CcSEcCtD
Carbimazole—Nausea—Paclitaxel—breast cancer	4.8e-05	0.000412	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX2—breast cancer	4.8e-05	0.000756	CbGpPWpGaD
Carbimazole—Skin disorder—Methotrexate—breast cancer	4.79e-05	0.000411	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.79e-05	0.000411	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP2D6—breast cancer	4.77e-05	0.00075	CbGpPWpGaD
Carbimazole—Discomfort—Epirubicin—breast cancer	4.76e-05	0.000409	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX4—breast cancer	4.74e-05	0.000746	CbGpPWpGaD
Carbimazole—Malaise—Doxorubicin—breast cancer	4.72e-05	0.000405	CcSEcCtD
Carbimazole—Pruritus—Capecitabine—breast cancer	4.69e-05	0.000403	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—breast cancer	4.69e-05	0.000402	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA2—breast cancer	4.68e-05	0.000737	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—breast cancer	4.63e-05	0.000729	CbGpPWpGaD
Carbimazole—Infection—Epirubicin—breast cancer	4.59e-05	0.000394	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—breast cancer	4.56e-05	0.000718	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FASN—breast cancer	4.54e-05	0.000714	CbGpPWpGaD
Carbimazole—Nervous system disorder—Epirubicin—breast cancer	4.53e-05	0.000389	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—breast cancer	4.52e-05	0.000388	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—breast cancer	4.52e-05	0.000712	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BCHE—breast cancer	4.52e-05	0.000711	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Methotrexate—breast cancer	4.5e-05	0.000386	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—SYNJ2—breast cancer	4.49e-05	0.000707	CbGpPWpGaD
Carbimazole—Skin disorder—Epirubicin—breast cancer	4.49e-05	0.000385	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RB1—breast cancer	4.48e-05	0.000706	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—breast cancer	4.47e-05	0.000703	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A5—breast cancer	4.46e-05	0.000703	CbGpPWpGaD
Carbimazole—Myalgia—Doxorubicin—breast cancer	4.46e-05	0.000383	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—breast cancer	4.46e-05	0.000383	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.43e-05	0.00038	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—breast cancer	4.4e-05	0.000378	CcSEcCtD
Carbimazole—Rash—Docetaxel—breast cancer	4.32e-05	0.000371	CcSEcCtD
Carbimazole—Dermatitis—Docetaxel—breast cancer	4.31e-05	0.00037	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC2A1—breast cancer	4.31e-05	0.000679	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NQO1—breast cancer	4.31e-05	0.000679	CbGpPWpGaD
Carbimazole—Headache—Docetaxel—breast cancer	4.29e-05	0.000368	CcSEcCtD
Carbimazole—Infection—Doxorubicin—breast cancer	4.25e-05	0.000364	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—breast cancer	4.21e-05	0.000361	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP3A4—breast cancer	4.2e-05	0.000662	CbGpPWpGaD
Carbimazole—Nervous system disorder—Doxorubicin—breast cancer	4.19e-05	0.00036	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—breast cancer	4.18e-05	0.000359	CcSEcCtD
Carbimazole—Rash—Capecitabine—breast cancer	4.18e-05	0.000359	CcSEcCtD
Carbimazole—Dermatitis—Capecitabine—breast cancer	4.18e-05	0.000358	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—NDUFS3—breast cancer	4.17e-05	0.000657	CbGpPWpGaD
Carbimazole—Headache—Capecitabine—breast cancer	4.15e-05	0.000357	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—breast cancer	4.15e-05	0.000356	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP1B1—breast cancer	4.13e-05	0.000651	CbGpPWpGaD
Carbimazole—Nausea—Docetaxel—breast cancer	4.07e-05	0.000349	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—breast cancer	4.07e-05	0.000349	CcSEcCtD
Carbimazole—TPO—Metabolism—HSP90AA1—breast cancer	4.05e-05	0.000638	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.01e-05	0.000632	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NCOA1—breast cancer	3.94e-05	0.000621	CbGpPWpGaD
Carbimazole—Nausea—Capecitabine—breast cancer	3.94e-05	0.000338	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CHST9—breast cancer	3.92e-05	0.000618	CbGpPWpGaD
Carbimazole—Urticaria—Methotrexate—breast cancer	3.92e-05	0.000337	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—breast cancer	3.9e-05	0.000335	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.89e-05	0.000334	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP19A1—breast cancer	3.89e-05	0.000612	CbGpPWpGaD
Carbimazole—TPO—Metabolism—STK11—breast cancer	3.89e-05	0.000612	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—breast cancer	3.88e-05	0.000611	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.84e-05	0.000604	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—breast cancer	3.82e-05	0.000602	CbGpPWpGaD
Carbimazole—Feeling abnormal—Epirubicin—breast cancer	3.81e-05	0.000327	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	3.73e-05	0.000588	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—COX11—breast cancer	3.72e-05	0.000586	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—breast cancer	3.72e-05	0.000585	CbGpPWpGaD
Carbimazole—Urticaria—Epirubicin—breast cancer	3.67e-05	0.000315	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.66e-05	0.000576	CbGpPWpGaD
Carbimazole—Body temperature increased—Epirubicin—breast cancer	3.65e-05	0.000313	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—breast cancer	3.64e-05	0.000312	CcSEcCtD
Carbimazole—TPO—Metabolism—COMT—breast cancer	3.61e-05	0.000569	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—breast cancer	3.6e-05	0.000566	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.55e-05	0.000559	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMOX1—breast cancer	3.55e-05	0.000558	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ITPR1—breast cancer	3.54e-05	0.000557	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—breast cancer	3.52e-05	0.000302	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—breast cancer	3.49e-05	0.0003	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—breast cancer	3.42e-05	0.000538	CbGpPWpGaD
Carbimazole—Hypersensitivity—Epirubicin—breast cancer	3.4e-05	0.000292	CcSEcCtD
Carbimazole—TPO—Metabolism—ABCB1—breast cancer	3.4e-05	0.000536	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SHMT1—breast cancer	3.4e-05	0.000536	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CDA—breast cancer	3.4e-05	0.000536	CbGpPWpGaD
Carbimazole—Urticaria—Doxorubicin—breast cancer	3.4e-05	0.000291	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—breast cancer	3.38e-05	0.00029	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.36e-05	0.000529	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TYMS—breast cancer	3.34e-05	0.000526	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—breast cancer	3.33e-05	0.000524	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.33e-05	0.000524	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—breast cancer	3.32e-05	0.000523	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLA2G4A—breast cancer	3.3e-05	0.00052	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NCOR1—breast cancer	3.3e-05	0.00052	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—breast cancer	3.3e-05	0.00052	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—breast cancer	3.3e-05	0.000519	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A5—breast cancer	3.28e-05	0.000516	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLCO1B1—breast cancer	3.28e-05	0.000516	CbGpPWpGaD
Carbimazole—Pruritus—Epirubicin—breast cancer	3.27e-05	0.00028	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—breast cancer	3.21e-05	0.000506	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.2e-05	0.000504	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APRT—breast cancer	3.16e-05	0.000498	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX1—breast cancer	3.16e-05	0.000498	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—breast cancer	3.15e-05	0.00027	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP1A1—breast cancer	3.13e-05	0.000493	CbGpPWpGaD
Carbimazole—Rash—Methotrexate—breast cancer	3.11e-05	0.000267	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—breast cancer	3.11e-05	0.000267	CcSEcCtD
Carbimazole—TPO—Metabolism—ERCC2—breast cancer	3.11e-05	0.000489	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.11e-05	0.000489	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.09e-05	0.000487	CbGpPWpGaD
Carbimazole—Headache—Methotrexate—breast cancer	3.09e-05	0.000265	CcSEcCtD
Carbimazole—Pruritus—Doxorubicin—breast cancer	3.02e-05	0.00026	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—ESRRA—breast cancer	2.97e-05	0.000468	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ANGPTL4—breast cancer	2.97e-05	0.000468	CbGpPWpGaD
Carbimazole—Nausea—Methotrexate—breast cancer	2.93e-05	0.000252	CcSEcCtD
Carbimazole—TPO—Metabolism—MTHFR—breast cancer	2.92e-05	0.00046	CbGpPWpGaD
Carbimazole—Rash—Epirubicin—breast cancer	2.91e-05	0.00025	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—breast cancer	2.91e-05	0.00025	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—breast cancer	2.9e-05	0.000457	CbGpPWpGaD
Carbimazole—Headache—Epirubicin—breast cancer	2.89e-05	0.000248	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.83e-05	0.000445	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HADHB—breast cancer	2.82e-05	0.000444	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPI—breast cancer	2.82e-05	0.000444	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—breast cancer	2.74e-05	0.000235	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.7e-05	0.000425	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—breast cancer	2.69e-05	0.000231	CcSEcCtD
Carbimazole—TPO—Metabolism—CAV1—breast cancer	2.69e-05	0.000424	CbGpPWpGaD
Carbimazole—Dermatitis—Doxorubicin—breast cancer	2.69e-05	0.000231	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—ALDH1A1—breast cancer	2.69e-05	0.000424	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDH7A1—breast cancer	2.69e-05	0.000424	CbGpPWpGaD
Carbimazole—Headache—Doxorubicin—breast cancer	2.68e-05	0.00023	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—breast cancer	2.67e-05	0.00042	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—breast cancer	2.61e-05	0.000411	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADSL—breast cancer	2.58e-05	0.000406	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FHL2—breast cancer	2.58e-05	0.000406	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PHGDH—breast cancer	2.58e-05	0.000406	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NME1—breast cancer	2.58e-05	0.000406	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UMPS—breast cancer	2.58e-05	0.000406	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—breast cancer	2.54e-05	0.000218	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—HPSE—breast cancer	2.53e-05	0.000398	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BRIP1—breast cancer	2.53e-05	0.000398	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LDHB—breast cancer	2.53e-05	0.000398	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—breast cancer	2.47e-05	0.000388	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—breast cancer	2.45e-05	0.000386	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMMR—breast cancer	2.4e-05	0.000378	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA3—breast cancer	2.4e-05	0.000378	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCC1—breast cancer	2.4e-05	0.000378	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARGC1B—breast cancer	2.32e-05	0.000366	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.26e-05	0.000356	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.26e-05	0.000356	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA9—breast cancer	2.19e-05	0.000345	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA4—breast cancer	2.19e-05	0.000345	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	2.19e-05	0.000345	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.17e-05	0.000341	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—breast cancer	2.16e-05	0.00034	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.14e-05	0.000337	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA2—breast cancer	2.14e-05	0.000336	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX2—breast cancer	2.14e-05	0.000336	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—breast cancer	2.13e-05	0.000335	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX4—breast cancer	2.11e-05	0.000332	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SULT1A1—breast cancer	2.11e-05	0.000332	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—IDH1—breast cancer	2.06e-05	0.000325	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA1—breast cancer	2.06e-05	0.000325	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAT2—breast cancer	2.04e-05	0.000321	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NOS3—breast cancer	2.04e-05	0.000321	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—breast cancer	1.88e-05	0.000296	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—breast cancer	1.86e-05	0.000293	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	1.85e-05	0.000292	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.84e-05	0.00029	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MED12—breast cancer	1.79e-05	0.000281	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—DPYD—breast cancer	1.79e-05	0.000281	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDOA—breast cancer	1.76e-05	0.000277	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA3—breast cancer	1.71e-05	0.000269	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A2—breast cancer	1.7e-05	0.000267	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.68e-05	0.000264	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTR—breast cancer	1.66e-05	0.000262	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CPT1A—breast cancer	1.66e-05	0.000262	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG2—breast cancer	1.66e-05	0.000262	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPGDS—breast cancer	1.63e-05	0.000257	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—breast cancer	1.62e-05	0.000256	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HBA1—breast cancer	1.62e-05	0.000255	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACHE—breast cancer	1.58e-05	0.000249	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—breast cancer	1.58e-05	0.000249	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP17A1—breast cancer	1.5e-05	0.000236	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS1—breast cancer	1.48e-05	0.000233	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENO1—breast cancer	1.48e-05	0.000233	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.48e-05	0.000232	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.46e-05	0.000229	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2D6—breast cancer	1.45e-05	0.000229	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA2—breast cancer	1.43e-05	0.000225	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FASN—breast cancer	1.38e-05	0.000218	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCHE—breast cancer	1.38e-05	0.000217	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A5—breast cancer	1.36e-05	0.000214	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A1—breast cancer	1.31e-05	0.000207	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NQO1—breast cancer	1.31e-05	0.000207	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.29e-05	0.000203	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP3A4—breast cancer	1.28e-05	0.000202	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.27e-05	0.000201	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1B1—breast cancer	1.26e-05	0.000198	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSP90AA1—breast cancer	1.24e-05	0.000194	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA1—breast cancer	1.2e-05	0.000189	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STK11—breast cancer	1.18e-05	0.000186	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—breast cancer	1.15e-05	0.00018	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.11e-05	0.000175	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—COMT—breast cancer	1.1e-05	0.000173	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—breast cancer	1.1e-05	0.000173	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMOX1—breast cancer	1.08e-05	0.00017	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ITPR1—breast cancer	1.08e-05	0.00017	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—breast cancer	1.04e-05	0.000163	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TYMS—breast cancer	1.02e-05	0.00016	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLA2G4A—breast cancer	1.01e-05	0.000159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—breast cancer	1.01e-05	0.000159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOR1—breast cancer	1.01e-05	0.000159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX1—breast cancer	9.64e-06	0.000152	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—breast cancer	9.55e-06	0.00015	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ERCC2—breast cancer	9.47e-06	0.000149	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—breast cancer	9.36e-06	0.000147	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—breast cancer	8.9e-06	0.00014	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAV1—breast cancer	8.21e-06	0.000129	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.84e-06	0.000123	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—breast cancer	7.48e-06	0.000118	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—breast cancer	6.57e-06	0.000103	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—breast cancer	6.49e-06	0.000102	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NOS3—breast cancer	6.21e-06	9.77e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—breast cancer	5.73e-06	9.02e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—breast cancer	5.68e-06	8.94e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—breast cancer	4.95e-06	7.79e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—breast cancer	3.49e-06	5.5e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—breast cancer	2.85e-06	4.49e-05	CbGpPWpGaD
